West Coast Metabolomics Center, University of California, Davis, Davis, CA, USA.
Departments of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Sci Rep. 2018 Aug 8;8(1):11883. doi: 10.1038/s41598-018-29592-3.
The biological basis for gender variability among disease states is not well established. There have been many prior efforts attempting to identify the unique urine metabolomic profiles associated with specific diseases. However, there has been little advancement in investigating the metabolomic differences associated with gender, which underlies the misconception that risk factors and treatment regimens should be the same for both male and female patients. This present study aimed to identify biologically-meaningful baseline sex-related differences using urine samples provided by healthy female and male participants. To elucidate whether urinary metabolic signatures are globally distinct between healthy males and females, we applied metabolomics profiling of primary metabolism with comprehensive bioinformatics analyses on urine samples from 60 healthy males and females. We found that levels of α-ketoglutarate and 4-hydroxybutyric acid increased 2.3-fold and 4.41-fold in males compared to females, respectively. Furthermore, chemical similarity enrichment analysis revealed that differentially expressed metabolites, such as saturated fatty acids, TCA, and butyrates, were significantly related to the gender effect. These findings indicate that there are baseline sex-related differences in urinary metabolism, which should be considered in biomarker discovery, diagnosis, and treatment of bladder diseases, such as interstitial cystitis.
疾病状态下性别变异性的生物学基础尚未得到很好的确立。先前已经有许多努力试图确定与特定疾病相关的独特尿液代谢组学特征。然而,在研究与性别相关的代谢差异方面进展甚微,这导致了一个误解,即风险因素和治疗方案应该对男性和女性患者都相同。本研究旨在使用健康女性和男性参与者提供的尿液样本,确定具有生物学意义的基线性别差异。为了阐明健康男性和女性之间的尿液代谢特征是否存在全局差异,我们对来自 60 名健康男性和女性的尿液样本进行了主代谢物的代谢组学分析,并结合全面的生物信息学分析。我们发现,与女性相比,男性的α-酮戊二酸和 4-羟基丁酸水平分别增加了 2.3 倍和 4.41 倍。此外,化学相似性富集分析表明,差异表达的代谢物,如饱和脂肪酸、三羧酸 (TCA) 和丁酸盐,与性别效应显著相关。这些发现表明,尿液代谢存在基线性别差异,这在膀胱疾病(如间质性膀胱炎)的生物标志物发现、诊断和治疗中应予以考虑。